Search
00
GBAF Logo
trophy
Top StoriesInterviewsBusinessFinanceBankingTechnologyInvestingTradingVideosAwardsMagazinesHeadlinesTrends

Subscribe to our newsletter

Get the latest news and updates from our team.

Global Banking and Finance Review

Company

    GBAF Logo
    • About Us
    • Profile
    • Privacy & Cookie Policy
    • Terms of Use
    • Contact Us
    • Advertising
    • Submit Post
    • Latest News
    • Research Reports
    • Press Release
    • Awards▾
      • About the Awards
      • Awards TimeTable
      • Submit Nominations
      • Testimonials
      • Media Room
      • Award Winners
      • FAQ
    • Magazines▾
      • Global Banking & Finance Review Magazine Issue 79
      • Global Banking & Finance Review Magazine Issue 78
      • Global Banking & Finance Review Magazine Issue 77
      • Global Banking & Finance Review Magazine Issue 76
      • Global Banking & Finance Review Magazine Issue 75
      • Global Banking & Finance Review Magazine Issue 73
      • Global Banking & Finance Review Magazine Issue 71
      • Global Banking & Finance Review Magazine Issue 70
      • Global Banking & Finance Review Magazine Issue 69
      • Global Banking & Finance Review Magazine Issue 66
    Top StoriesInterviewsBusinessFinanceBankingTechnologyInvestingTradingVideosAwardsMagazinesHeadlinesTrends

    Global Banking & Finance Review® is a leading financial portal and online magazine offering News, Analysis, Opinion, Reviews, Interviews & Videos from the world of Banking, Finance, Business, Trading, Technology, Investing, Brokerage, Foreign Exchange, Tax & Legal, Islamic Finance, Asset & Wealth Management.
    Copyright © 2010-2026 GBAF Publications Ltd - All Rights Reserved. | Sitemap | Tags

    Editorial & Advertiser disclosure

    Global Banking and Finance Review is an online platform offering news, analysis, and opinion on the latest trends, developments, and innovations in the banking and finance industry worldwide. The platform covers a diverse range of topics, including banking, insurance, investment, wealth management, fintech, and regulatory issues. The website publishes news, press releases, opinion and advertorials on various financial organizations, products and services which are commissioned from various Companies, Organizations, PR agencies, Bloggers etc. These commissioned articles are commercial in nature. This is not to be considered as financial advice and should be considered only for information purposes. It does not reflect the views or opinion of our website and is not to be considered an endorsement or a recommendation. We cannot guarantee the accuracy or applicability of any information provided with respect to your individual or personal circumstances. Please seek Professional advice from a qualified professional before making any financial decisions. We link to various third-party websites, affiliate sales networks, and to our advertising partners websites. When you view or click on certain links available on our articles, our partners may compensate us for displaying the content to you or make a purchase or fill a form. This will not incur any additional charges to you. To make things simpler for you to identity or distinguish advertised or sponsored articles or links, you may consider all articles or links hosted on our site as a commercial article placement. We will not be responsible for any loss you may suffer as a result of any omission or inaccuracy on the website.

    Home > Finance > Roche earnings edge up 5% as forex effects weigh on drug sales growth
    Finance
    Roche earnings edge up 5% as forex effects weigh on drug sales growth

    Published by Global Banking and Finance Review

    Posted on January 29, 2026

    1 min read

    Last updated: January 29, 2026

    Roche earnings edge up 5% as forex effects weigh on drug sales growth - Finance news and analysis from Global Banking & Finance Review
    Tags:financial communitycorporate profitsfinancial marketsinvestment portfolioscapital gain

    Quick Summary

    Roche forecasts high single-digit earnings growth and mid single-digit sales growth by 2026, as announced in Frankfurt.

    Table of Contents

    • Roche's Financial Performance Overview
    • Operating Income and Market Expectations
    • Future Sales and Earnings Projections

    Roche Reports 5% Increase in Earnings Amid Currency Challenges

    Roche's Financial Performance Overview

    By Ludwig Burger

    Operating Income and Market Expectations

    FRANKFURT, Jan 29 (Reuters) - Roche's full-year adjusted operating income rose by a lower-than-expected 5% as gains in drugs such as Phesgo against breast cancer and Hemlibra against haemophilia were partly offset by a weak U.S. dollar weighing on overseas sales.

    Future Sales and Earnings Projections

    Operating profit, adjusted for special items, came in at 21.8 billion Swiss francs ($28.5 billion) in 2025, the Swiss drugmaker said in a statement on Thursday, just shy of a market consensus of 22 billion francs cited by analysts.

    The group also said it expects 2026 group sales to grow in the mid single-digit percentage range, while targeting core earnings per share growth in the high single-digit range.

    (Reporting by Ludwig Burger, Editing by Friederike Heine)

    Key Takeaways

    • •Roche expects high single-digit earnings growth by 2026.
    • •Group sales are projected to grow in the mid single-digit range.
    • •The announcement was made in Frankfurt on January 29.
    • •Ludwig Burger reported the news, edited by Friederike Heine.
    • •Roche is focusing on core earnings per share growth.

    Frequently Asked Questions about Roche earnings edge up 5% as forex effects weigh on drug sales growth

    1What are core earnings?

    Core earnings are the profits generated from a company's primary business operations, excluding any income from non-operational activities like investments or sales of assets. They provide a clearer picture of operational performance.

    2What is group sales?

    Group sales refer to the total revenue generated by a company from all its business segments combined. It reflects the overall market performance and demand for the company's products or services.

    3What is a financial projection?

    A financial projection is an estimate of a company's future financial performance, including revenue, expenses, and profits. It is based on historical data and market analysis, helping businesses plan and make informed decisions.

    Why waste money on news and opinion when you can access them for free?

    Take advantage of our newsletter subscription and stay informed on the go!

    Subscribe

    More from Finance

    Explore more articles in the Finance category

    Deezer licenses AI-detection tool to French royalty agency Sacem, plans wider roll-out
    Fevertree Drinks lifts 2025 revenue and profit forecasts
    Crest Nicholson warns of weak demand after annual profit miss
    UK's Hilton Food sees higher impact from US salmon stock write-off
    UK's Ocado says Canadian partner to close warehouse in latest blow
    Starmer and Xi discussed tariffs, travel and migration
    UK's Saga sees higher annual profit on cruise and travel demand
    Tesla shares up 1.8% in Frankfurt day after results
    Glencore reports 2025 copper output fell 11% as Rio Tinto tie-up looms
    Canal+ expects over 400 million euros in synergies from MultiChoice deal
    Cognac maker Remy Cointreau tops sales forecasts as US improves
    Meta shares rise in Frankfurt after results, capital plans
    View All Finance Posts
    Previous Finance PostIndia’s textile exporters pin hopes on EU deal after US tariff blow
    Next Finance PostNokia to replace board chair, AI push supports Q4 profit